ProciseDx

FDA Approves 5-Minute Tests for Monitoring Humira and Remicade Doses in Inflammatory Bowel Disease Patients

FDA Approves 5-Minute Tests for Monitoring Humira and Remicade Doses in Inflammatory Bowel Disease Patients

Anika Sharma

The FDA has recently granted two de novo clearances to ProciseDx, marking a significant advancement in personalized medicine for patients ...